Thermo Fisher Scientific
TMO
974 hedge funds and large institutions have $45.8B invested in Thermo Fisher Scientific in 2015 Q2 according to their latest regulatory filings, with 84 funds opening new positions, 325 increasing their positions, 377 reducing their positions, and 63 closing their positions.
79% more call options, than puts
Call options by funds: $329M | Put options by funds: $184M
33% more first-time investments, than exits
New positions opened: 84 | Existing positions closed: 63
1% more funds holding
Funds holding: 964 → 974 (+10)
5% less capital invested
Capital invested by funds: $48B → $45.8B (-$2.2B)
1.37% less ownership
Funds ownership: 90.17% → 88.8% (-1.4%)
7% less funds holding in top 10
Funds holding in top 10: 75 → 70 (-5)
14% less repeat investments, than reductions
Existing positions increased: 325 | Existing positions reduced: 377
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCM
Glenview Capital Management
New York
|
+$306M |
| 2 |
SC
Sculptor Capital
New York
|
+$164M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
+$97M |
| 4 |
Prudential Financial
Newark,
New Jersey
|
+$91.2M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$67.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
-$433M |
| 2 |
EPCM
Eton Park Capital Management
New York
|
-$210M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$155M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$121M |
| 5 |
BRC
Blue Ridge Capital
New York
|
-$99.1M |
TMO Hedge Fund Activity: Q2 2015 in Review
974 of the 3,712 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q2 2015, worth a combined $45.8B — down 4.6% from $48B a quarter earlier.
Buyers outnumbered sellers: 84 funds opened new TMO positions and 63 closed out — a net gain of 21 holders — while 325 added to existing stakes and 377 trimmed.
The largest buyer was Glenview Capital Management, adding an estimated $306M. The largest seller was Viking Global Investors, cutting an estimated $433M.
- 974 institutional investors held Thermo Fisher Scientific (TMO) as of Q2 2015, up from 964 in Q1 2015.
- Funds reported $45.8B of Thermo Fisher Scientific stock for Q2 2015, down 4.6% quarter-over-quarter.
- 84 funds opened new Thermo Fisher Scientific positions in Q2 2015 and 63 closed out, a net change of +21 holders.
- The largest Thermo Fisher Scientific buyer in Q2 2015 was Glenview Capital Management, an estimated $306M added.
- The largest Thermo Fisher Scientific seller in Q2 2015 was Viking Global Investors, an estimated $433M sold.
Based on aggregated 13F filings for Q2 2015.